Skip to main content

Celldex Therapeutics, Inc.

CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000744218

No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.16B in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Celldex Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
160
+2 vs. Q2 2022
Shares held
49.0M
+1.09M (+2.3%) vs. Q2 2022
Total value
$1.39B
+$86.3M (+6.6%) vs. Q2 2022
New holders
26
57 more added
Sold out
24
39 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CLDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 160 institutions
Q1 2021: 115 institutionsQ2 2021: 132 institutionsQ3 2021: 161 institutionsQ4 2021: 181 institutionsQ1 2022: 169 institutionsQ2 2022: 158 institutionsQ3 2022: 160 institutionsQ4 2022: 168 institutionsQ1 2023: 161 institutionsQ2 2023: 150 institutionsQ3 2023: 144 institutionsQ4 2023: 164 institutionsQ1 2024: 197 institutionsQ2 2024: 183 institutionsQ3 2024: 176 institutionsQ4 2024: 174 institutionsQ1 2025: 171 institutionsQ2 2025: 182 institutionsQ3 2025: 184 institutionsQ4 2025: 187 institutionsQ1 2026: 229 institutionsQ2 2026: 253 institutions
Value heldQ3 2022: $1.39B
Q1 2021: $709.5MQ2 2021: $1.19BQ3 2021: $2.33BQ4 2021: $1.79BQ1 2022: $1.69BQ2 2022: $1.30BQ3 2022: $1.39BQ4 2022: $2.17BQ1 2023: $1.78BQ2 2023: $1.70BQ3 2023: $1.39BQ4 2023: $2.42BQ1 2024: $2.91BQ2 2024: $2.58BQ3 2024: $2.44BQ4 2024: $1.86BQ1 2025: $1.34BQ2 2025: $1.48BQ3 2025: $1.83BQ4 2025: $1.99BQ1 2026: $2.31BQ2 2026: $3.16B
Institutions holding CLDX and their total value by quarter
QuarterHoldersValue
Q2 2026253$3.16B
Q1 2026229$2.31B
Q4 2025187$1.99B
Q3 2025184$1.83B
Q2 2025182$1.48B
Q1 2025171$1.34B
Q4 2024174$1.86B
Q3 2024176$2.44B
Q2 2024183$2.58B
Q1 2024197$2.91B
Q4 2023164$2.42B
Q3 2023144$1.39B
Q2 2023150$1.70B
Q1 2023161$1.78B
Q4 2022168$2.17B
Q3 2022160$1.39B
Q2 2022158$1.30B
Q1 2022169$1.69B
Q4 2021181$1.79B
Q3 2021161$2.33B
Q2 2021132$1.19B
Q1 2021115$709.5M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Celldex Therapeutics, Inc.; share changes are against Q2 2022.

Institutions holding CLDX in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
ClariVest Asset Management LLC72,919$2.05M0.10%+56,519+344.6%Added
BNP Paribas Arbitrage, SA74,771$2.10M0.01%+64,865+654.8%Added
VR Adviser, LLC75,000$2.11M0.33%−790,116−91.3%Reduced
Affinity Asset Advisors, LLC80,000$2.25M1.04%+40,000+100.0%Added
Connor, Clark & Lunn Investment Management Ltd.80,650$2.27M0.01%+80,650New
Kennedy Capital Management, Inc.81,350$2.29M0.07%+57,034+234.6%Added
Prudential Financial Inc81,621$2.29M0.00%+81,621New
Swiss National Bank88,200$2.48M0.00%00.0%Unchanged
Mirador Capital Partners LP107,128$3.01M0.73%+760+0.7%Added
D. E. Shaw & Co., Inc.108,665$3.06M0.01%−33,055−23.3%Reduced
Two Sigma Advisers, LP120,100$3.38M0.01%−109,800−47.8%Reduced
Bank of America Corp130,990$3.68M0.00%+49,268+60.3%Added
Point72 Asset Management, L.P.135,000$3.79M0.02%+135,000New
Susquehanna International Group, LLP141,551$3.98M0.01%+119,586+544.4%Added
Barclays PLC144,587$4.06M0.00%+47,500+48.9%Added
Nuveen Asset Management, LLC149,646$4.21M0.00%−4,324−2.8%Reduced
AXA S.A.159,219$4.48M0.02%+31,403+24.6%Added
Tang Capital Management LLC160,219$4.50M0.55%+160,219New
Bank of New York Mellon Corp162,782$4.58M0.00%+13,197+8.8%Added
Casdin Capital, LLC165,000$4.64M0.31%00.0%Unchanged
Walleye Capital LLC171,902$4.83M0.11%+171,902New
Citigroup Inc189,412$5.32M0.01%+33,735+21.7%Added
American Century Companies Inc195,562$5.50M0.00%−723−0.4%Reduced
Vivo Capital, LLC198,983$5.59M0.62%−359,653−64.4%Reduced
Morgan Stanley203,383$5.72M0.00%−278,644−57.8%Reduced
GMT Capital Corp204,535$5.75M0.36%00.0%Unchanged
Rafferty Asset Management, LLC207,693$5.84M0.06%+83,887+67.8%Added
Sessa Capital IM, L.P.212,000$5.96M0.43%00.0%Unchanged
Tri Locum Partners LP238,569$6.71M1.91%+106,421+80.5%Added
Acuta Capital Partners, LLC267,195$7.51M3.34%00.0%Unchanged
TSP Capital Management Group, LLC–$7.51M3.17%––
Ikarian Capital, LLC317,476$8.92M4.45%−220,482−41.0%Reduced
Charles Schwab Investment Management Inc337,531$9.49M0.00%+6,972+2.1%Added
Candriam Luxembourg S.C.A.418,509$11.8M0.08%+127,715+43.9%Added
Rock Springs Capital Management LP421,604$11.9M0.31%+86,127+25.7%Added
Northern Trust Corp422,241$11.9M0.00%−1,426−0.3%Reduced
Fred Alger Management, LLC443,642$12.5M0.06%+200,259+82.3%Added
Dimensional Fund Advisors LP534,515$15.0M0.01%−77,357−12.6%Reduced
Commodore Capital LP538,812$15.1M2.44%00.0%Unchanged
Eversept Partners, LP626,372$17.6M2.09%+73,984+13.4%Added
Marshall Wace, LLP652,721$18.3M0.05%+632,698+3,159.9%Added
Goldman Sachs Group Inc664,431$18.7M0.01%+224,719+51.1%Added
Price T Rowe Associates Inc746,008$21.0M0.00%+212,606+39.9%Added
Octagon Capital Advisors LP761,398$21.4M3.69%00.0%Unchanged
Geode Capital Management, LLC852,706$24.0M0.00%+11,582+1.4%Added
Jennison Associates LLC1,274,021$35.8M0.04%+1,274,021New
Polar Capital Holdings Plc1,448,934$40.7M0.33%+801,514+123.8%Added
Citadel Advisors LLC1,501,094$42.2M0.05%+457,067+43.8%Added
Kynam Capital Management, LP1,600,127$45.0M9.50%+467,868+41.3%Added
Eventide Asset Management, LLC1,791,800$50.4M0.99%+346,100+23.9%Added
Bellevue Group AG1,800,000$50.6M0.73%+875,000+94.6%Added
Redmile Group, LLC1,985,151$55.8M2.16%−85,137−4.1%Reduced
Ra Capital Management, L.P.2,075,000$58.3M1.24%00.0%Unchanged
Vanguard Group Inc2,475,381$69.6M0.00%+40,009+1.6%Added
Wellington Management Group LLP3,080,733$86.6M0.02%+240,350+8.5%Added
RTW Investments, LP3,084,215$86.7M2.00%00.0%Unchanged
BlackRock Inc.3,130,413$88.0M0.00%−21,056−0.7%Reduced
State Street Corp3,171,578$89.2M0.01%−57,274−1.8%Reduced
FMR LLC7,015,843$197.2M0.02%+2,6990.0%Added
IFP Advisors, Inc29––00.0%Unchanged
Viking Global Investors LPSuperinvestorViking Global Investors0$00.00%−2,337,854−100.0%Sold out
Adage Capital Partners GP, L.L.C.0$00.00%−400,000−100.0%Sold out
Cormorant Asset Management, LP0$00.00%−200,000−100.0%Sold out
BVF Inc0$00.00%−154,000−100.0%Sold out
Millennium Management LLC0$00.00%−143,343−100.0%Sold out
OrbiMed Advisors LLC0$00.00%−112,700−100.0%Sold out
Polar Asset Management Partners Inc.0$00.00%−98,600−100.0%Sold out
Norges Bank0$00.00%−92,900−100.0%Sold out
Opaleye Management Inc.0$00.00%−90,000−100.0%Sold out
Squarepoint Ops LLC0$00.00%−78,345−100.0%Sold out
Woodline Partners LP0$00.00%−64,454−100.0%Sold out
Jefferies Group LLC0$00.00%−59,098−100.0%Sold out
Sofinnova Investments, Inc.0$00.00%−48,304−100.0%Sold out
DLD Asset Management, LP0$00.00%−36,000−100.0%Sold out
Altshuler Shaham Ltd0$00.00%−32,000−100.0%Sold out
Winton Group Ltd0$00.00%−8,322−100.0%Sold out
Janus Henderson Group PLC0$00.00%−8,062−100.0%Sold out
Campbell & CO Investment Adviser LLC0$00.00%−8,052−100.0%Sold out
Captrust Financial Advisors0$00.00%−618−100.0%Sold out
State of Wyoming0$00.00%−214−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−132−100.0%Sold out
Meeder Asset Management Inc0$00.00%−33−100.0%Sold out
Venture Visionary Partners LLC0$00.00%−10−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−16−100.0%Sold out